CSF neurogranin or tau distinguish typical and atypical Alzheimer disease
Open Access
- 11 January 2018
- journal article
- research article
- Published by Wiley in Annals of Clinical and Translational Neurology
- Vol. 5 (2) , 162-171
Abstract
Objective: To assess whether high levels of cerebrospinal fluid neurogranin are found in atypical as well as typical Alzheimer's disease.Methods: Immunoassays were used to measure cerebrospinal fluid neurogranin in 114 participants including healthy controls (n = 27), biomarker‐proven amnestic Alzheimer's disease (n = 68), and the atypical visual variant of Alzheimer's (n = 19) according to international criteria. CSF total‐tau, Aβ42, and neurofilament light concentrations were investigated using commercially available assays. All affected individuals had T1‐weighted volumetric MR images available for analysis of whole and regional brain volumes. Associations between neurogranin, brain volumes, total‐tau, Aβ42, and neurofilament light were assessed.Results: Median cerebrospinal fluid neurogranin concentrations were higher in typical and atypical Alzheimer's compared to controls (P < 0.001 and P = 0.005). Both neurogranin and total‐tau concentrations, but not neurofilament light and Aβ42, were higher in typical Alzheimer's compared to atypical patients (P = 0.004 and P = 0.03). There were significant differences in the left hippocampus and right and left superior parietal lobules in atypical patients, which were larger (P = 0.03) and smaller (P = 0.001 and P < 0.001), respectively, compared to typical patients. We found no evidence of associations between neurogranin and brain volumes but a strong association with total‐tau (P < 0.001) and a weaker association with neurofilament light (P = 0.005).Interpretation: These results show significant differences in neurogranin and total‐tau between typical and atypical patients, which may relate to factors other than disease topography. The differential relationships between neurogranin, total‐tau and neurofilament light in the Alzheimer's variants, provide evidence for mechanistically distinct and coupled markers of neurodegeneration.Keywords
Funding Information
- Wolfson Foundation
- Alzheimer’s Research UK (ARUK-Network 2012-6-ICE, ARUK-PG2014-1946)
- National Institute for Health Research
- University College London
- Engineering and Physical Sciences Research Council (EP/J020990/1)
- Medical Research Council (CSUB19166)
- Horizon 2020 Framework Programme (666992)
This publication has 40 references indexed in Scilit:
- Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's diseaseNeurobiology of Aging, 2017
- Cerebrospinal fluid tau, neurogranin, and neurofilament light in Alzheimer's diseaseEMBO Molecular Medicine, 2016
- Cerebrospinal fluid biomarkers and cerebral atrophy in distinct clinical variants of probable Alzheimer's diseaseNeurobiology of Aging, 2015
- Geodesic Information Flows: Spatially-Variant Graphs and Their Application to Segmentation and FusionIEEE Transactions on Medical Imaging, 2015
- A panel of nine cerebrospinal fluid biomarkers may identify patients with atypical parkinsonian syndromesJournal of Neurology, Neurosurgery & Psychiatry, 2015
- Cerebrospinal fluid levels of the synaptic protein neurogranin correlates with cognitive decline in prodromal Alzheimer's diseaseAlzheimer's & Dementia, 2014
- Total and phosphorylated tau protein as biological markers of Alzheimer’s diseaseExperimental Gerontology, 2010
- Dendritic Translocation of RC3/Neurogranin mRNA in Normal Aging, Alzheimer Disease and Fronto-Temporal DementiaJournal of Neuropathology & Experimental Neurology, 1997
- Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairmentAnnals of Neurology, 1991
- Synapse loss in frontal cortex biopsies in Alzheimer's disease: Correlation with cognitive severityAnnals of Neurology, 1990